Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Uni-bio Science Group

2001 FOUNDED
PUBLIC STATUS
301-400 EMPLOYEES
00690 STOCK SYMBOL
$0.01 SHARE PRICE (As of Friday Closing)
Description

Manufacturer of pharmaceuticals designed to deliver, innovative, high-quality healthcare products for patients throughout China. The company is engaged in the research, development, production and commercialization of pharmaceuticals for the Chinese healthcare market.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Distributors (Healthcare)
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • Room 3006, 30th Floor
  • 60 Wyndham Street
  • Hong Kong
  • Hong Kong

+852 3102 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Uni-bio Science Group’s full profile, request a free trial.

Uni-bio Science Group Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.01 - $0.02 $75.5M $0.01 2.47M 6.16B

Uni-bio Science Group Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 76,727 113,605 85,408
Revenue 19,573 20,080 18,869 15,911
EBITDA (39,457) (31,902) (3,458) (3,672)
Net Income (39,469) (35,842) (7,178) (7,713)
Total Assets 40,460 49,940 64,130 71,842
Total Debt 0 0 1,417 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer